Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
GSK:LNLondon

GlaxoSmithKline PLC

COMPANY INFO
1,338.00GBp
-8.40-0.62%
Market Closed
As of 04/19/2021 EDT
Open
1,341.40
Prev Close
1,346.40
Volume
7,006,300
Market Cap
67.320B
Day Range
1,331.601,353.00
52 Week Range
1,190.801,742.40
1D1M1Y5Y
View Full Chart
Market Closed
As of 04/19/2021 EDT
1D1M1Y5Y
View Full Chart
News
Press Releases
business
CureVac Joins GlaxoSmithKline to Make Next-Gen Covid Shot
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio11.57
PEGY Ratio1.1695
Shares Outstanding5.03B
Price to Book Ratio4.6138
Price to Sales Ratio1.9524
1 Year Return-15.22%
30 Day Avg Volume8,641,836
EPS1.16
Dividend5.98%
Last Dividend Reported23
Earnings Announcement for Period Ending Q1/2021:04/28/2021

Compare
1-Day Performance

-1%0+1%
-1%0+1%
Equity
GSK:LN
-0.62%
Sponsored By

About GlaxoSmithKline PLC

GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
Address
980 Great West Road Brentford Middlesex United Kingdom
Phone
44-20-804-75000
Website
www.gsk.com

Income Statement

Quarterly
Annual
;
Q4 2020 (Millions GBP)
  • Revenue
    8,739.00
  • Net Income
    677.00
  • Profit Margin
    7.75%

Balance Sheet

Quarterly
Annual
;
Q4 2020 (Millions GBP)
  • Total Assets
    80,431.00
  • Total Liabilities
    59,623.00
  • Debt to Assets
    33.76%

Cash Flow

Quarterly
Annual
Q4 2020 (Millions GBP)
  • Operating
    3,531.00
  • Investing
    -75.00
  • Financing
    -1,850.00
Skip the following list of ads